Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples

Evosep Eno separation tool for LC-MS based proteomics

Proteomics company Evosep has launched Evosep Eno — a robust, high-throughput separation tool for next-generation workflow integration for LC-MS based proteomics. It should enhance Evosep’s ability to advance the use of LC-MS based proteomics as a vital tool for the pharmaceutical and biotech industries. Designed to drive the capabilities of next-generation LC-MS based proteomics, the product offers good standardisation, high performance and eas…

Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples

Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMICAssist Study—the world's largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and semi-state partners in the United Arab Emirates.